Bcl-XL and Akt cooperate to promote leukemogenesis in vivo

Oncogene

Volumn 22, Issue 5, 2003, Pages 688-698

  Karnauskas, Robyn ^a   Niu, Qun ^a   Talapatra, Sunit ^b   Plas, David R ^b   Greene, Marianne E ^a   Crispino, John D ^a   Rudin, Charles M ^a,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Akt; Bcl xL; Interleukin 3; Leukemia; P53

Indexed keywords

INTERLEUKIN 3; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN P53;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; IN VIVO STUDY; LEUKEMOGENESIS; LEUKOCYTOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; BCL-X PROTEIN; BLOOD CELLS; CELL TRANSFORMATION, NEOPLASTIC; INTERLEUKIN-3; LEUKEMIA; MICE; MICE, NUDE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; SPLEEN; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MURINAE;

EID: 0037421968     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206159     Document Type: Article

References (37)

1. Adams JM and Cory S. (2001). Trends Biochem. Sci., 26, 61-66.
2. Barlow C, Eckhaus MA, Schaffer AA and Wynshaw-Boris A. (1999). Nat. Genet., 21, 359-360.
3. Barthel A, Okino ST, Liao J, Nakatani K, Li J, Whitlock Jr JP and Roth RA. (1999). J Biol. Chem., 274, 20281-20286.
4. Bellacosa A, Franke TF, Gonzalez-Portal ME, Datta K, Taguchi T, Gardner J, Cheng JQ, Testa JR and Tsichlis PN. (1993). Oncogene, 8, 745-754.
5. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G and Thompson CB. (1993). Cell, 74, 597-608.
6. Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK and Testa JR. (1996). Proc. Natl. Acad. Sci. USA, 93, 3636-3641.
7. Cross DA, Watt PW, Shaw M, van der Kaay J, Dowries CP, Holder JC and Cohen P. (1997). FEBS Lett, 406, 211-215.
8. Datta SR, Brunet A and Greenberg ME. (1999). Genes Dev., 13, 2905-2927.
9. Della Ragione F, Mercurio C and Iolascon A. (1995). Haematologica, 80, 557-568.
10. Downward J. (1998). Curr. Opin. Genet. Dev., 8, 49-54.
11. Drexler HG, MacLeod RA, Borkhardt A and Janssen JW. (1995). Leukemia, 9, 480-500.
12. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB and Hay N. (2001). Genes Dev., 15, 1406-1418.
13. Huang Z. (2000). Oncogene, 19, 6627-6631.
14. Issa JP, Baylin SB and Herman JG. (1997). Leukemia, 11(Suppl. 1), S7-S11.
15. Klein G. (2000). BioEssays, 22, 414-422.
16. Komuro H, Valentine MB, Rubnitz JE, Saito M, Raimondi SC, Carroll AJ, Yi T, Sherr CJ and Look AT. (1999). Neoplasia, 1, 253-261.
17. Korsmeyer SJ. (1992). Annu. Rev. Immunol., 10, 785-807.
18. Lawlor MA and Alessi DR. (2001). J. Cell Sci., 114, 2903-2910.
19. Lund AH, Turner G, Trubetskoy A, Verhoeven E, Wientjens E, Hulsman D, Russell R, DePinho RA, Lenz J and van Lohuizen M. (2002). Nat. Genet., 32, 160-165.
20. McKeam JP, McCubrey J and Fagg B. (1985). Proc. Natl. Acad Sci. USA, 82, 7414-7418.
21. Minn AJ, Boise LH and Thompson CB. (1996). Genes Dev., 10, 2621-2631.
22. Minn AJ, Kettlun CS, Liang H, Kelekar A, Vander Heiden MG, Chang BS, Fesik SW, Fill M and Thompson CB. (1999). EMBO J., 18, 632-643.
23. Nicholson KM and Anderson NG. (2002). Cell Signal., 14, 381-395.
24. Plas DR, Talapatra S, Edinger AL, Rathmell JC and Thompson CB. (2001). J. Biol. Chem., 276, 12041-12048.
25. Plas DR and Thompson CB. (2002). Trends Endocrinol. Metab., 13, 75-78.
26. Rowley JD. (2000). Semin. Hematol., 37, 315-319.
27. Rudin CM and Thompson CB. (2001). Metabolic and Molecular Bases of Inherited Diseases, 8th edn. Scriver CR, Beaudet AL, Sly SW and Valle D (eds). McGraw-Hill: New York, pp. 631-644.
28. Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D, Ratajczak J, Resende IC, Haworth C, Hock R, Loh M, Felix C, Roy DC, Busque L, Kurnit D, Willman C, Gewirtz AM, Speck NA, Bushweller JH, Li FP, Gardiner K, Poncz M, Maris JM and Gilliland DG. (1999). Nat. Genet. 23, 166-175.
29. Shaulian E, Zauberman A, Ginzberg D and Oren M. (1992). Mol. Cell. Biol., 12, 5581-5592.
30. Staal SP (1987). Proc Natl. Acad. Sci. USA, 84, 5034-5037.
31. Talapatra S and Thompson CB. (2001). J. Pharmacol. Exp. Ther., 298, 873-878.
32. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT and Thompson CB. (1997). Cell, 91, 627-637.
33. Vander Heiden MG, Plas DR, Rathmell JR, Fox CJ, Harris MH and Thompson CB. (2001). Mol. Cell. Biol., 21, 5899-5912.
34. Vander Heiden MG and Thompson CB. (1999). Nat. Cell. Biol., 1, E209-E216.
35. Veldman T, Vignon C, Schrock E, Rowley JD and Ried T. (1997). Nat. Genet., 15, 406-410.
36. Weissman IL, Anderson DJ and Gage F. (2001). Annu. Rev. Cell Dev. Biol., 17, 387-403.
37. Xerri L, Hassoun J, Devilard E, Birnbaum D and Birg F. (1998). Leuk. Lymphoma, 28, 451-458.